分子測定法市場：技術別、製品別-2025-2030年の世界予測

分子測定法市場は、2023年に22億9,000万米ドルと評価され、2024年には24億2,000万米ドルに達すると予測され、CAGR 6.83％で成長し、2030年には36億4,000万米ドルに達すると予測されています。

分子測定法市場には、バイオマーカーの検出、特性評価、定量化を容易にするために、主に核酸とタンパク質の分析に焦点を当てた分子生物学で使用される様々な技術が含まれます。これらの手法には、ポリメラーゼ連鎖反応（PCR）、シーケンス技術、マイクロアレイ、その他ヘルスケア、農業、環境研究、製薬など様々な分野で不可欠な高度な生化学的手法が含まれます。分子測定法の必要性は、個別化医療、標的治療、および治療効果や患者の転帰を高めることを目的とした高度な診断ツールに対する需要の高まりに後押しされています。その用途は、研究やゲノム研究から臨床診断や医薬品開発まで多岐にわたる。エンドユーザーには、病院、研究機関、バイオテクノロジー企業、農業などが含まれます。市場に影響を与える主な成長要因としては、シーケンスおよびバイオインフォマティクスの技術的進歩、精密医療の台頭、遺伝子研究に対する資金提供の増加などが挙げられます。さらに、COVID-19の大流行は分子診断の重要性を浮き彫りにし、市場導入を加速させています。CRISPR技術の拡大、次世代シーケンサー（NGS）アプリケーションの開発、バイオマーカー探索に潜在的なビジネスチャンスがあります。しかし、高コスト、規制上のハードル、熟練した人材の必要性などの課題が、市場成長の加速を妨げています。技術革新と調査は、コスト削減とアクセシビリティ向上のための自動化、AIによるデータ解析能力の強化、合成生物学と遺伝子編集における新規アプリケーションの探求に向けられるのが最善です。市場情勢はダイナミックであり、技術的な複雑さや規制状況に対応できる企業には大きなチャンスがあります。企業はパートナーシップや研究協力に投資し、新たな技術を活用し、ニッチな用途と幅広い用途の両方に対応する包括的なソリューションを開発することで、将来の市場の需要に対応することをお勧めします。

市場力学：急速に進化する分子測定法市場の主要市場インサイトを公開

分子測定法市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 食品安全に対する需要の高まり
  • 感染症の流行増加
  • 環境工学における用途の増加
• 市場抑制要因
  • 認可のための厳しい規制基準
• 市場機会
  • 進行中の研究開発と分子技術の進歩
  • ゲノム研究の進展
• 市場の課題
  • 分子測定法の本質的限界

ポーターのファイブフォース：分子測定法市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、分子測定法市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：分子測定法市場における外部からの影響の把握

外部マクロ環境要因は、分子測定法市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析分子測定法市場における競合情勢の把握

分子測定法市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス分子測定法市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、分子測定法市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨分子測定法市場における成功への道筋を描く

分子測定法市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 食品安全に対する需要の高まり
    • 感染症の蔓延の増加
    • 環境工学における応用の増加
  • 抑制要因
    • 承認のための厳格な規制基準
  • 機会
    • 分子技術の継続的な研究開発と進歩
    • ゲノミクス分野の発展が加速
  • 課題
    • 分子測定法の固有の制限
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 分子測定法市場：技術別

• バイオセンサー
• 免疫測定
• マイクロアレイ
• ポリメラーゼ連鎖反応

第7章 分子測定法市場：製品別

• 機器
• 試薬・消耗品
• サービス

第8章 南北アメリカの分子測定法市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の分子測定法市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの分子測定法市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 3m Company
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• Danaher Corporation
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd
• HiMedia Laboratories LLC
• Invitae Corporation
• Neogen Corporation
• QIAGEN GmbH
• Sekisui Chemical Co., Ltd.
• SGS SA
• Siemens AG
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. MOLECULAR METHODS MARKET RESEARCH PROCESS
• FIGURE 2. MOLECULAR METHODS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MOLECULAR METHODS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MOLECULAR METHODS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. MOLECULAR METHODS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. MOLECULAR METHODS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MOLECULAR METHODS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MOLECULAR METHODS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MOLECULAR METHODS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MOLECULAR METHODS MARKET DYNAMICS
• TABLE 7. GLOBAL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MOLECULAR METHODS MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MOLECULAR METHODS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MOLECULAR METHODS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MOLECULAR METHODS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MOLECULAR METHODS MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MOLECULAR METHODS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MOLECULAR METHODS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. CANADA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 24. CANADA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. CHINA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. CHINA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. INDIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. INDIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. ITALY MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. ITALY MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. POLAND MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. POLAND MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. QATAR MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. QATAR MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. MOLECULAR METHODS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 103. MOLECULAR METHODS MARKET, FPNV POSITIONING MATRIX, 2023

The Molecular Methods Market was valued at USD 2.29 billion in 2023, expected to reach USD 2.42 billion in 2024, and is projected to grow at a CAGR of 6.83%, to USD 3.64 billion by 2030.

The molecular methods market encompasses various techniques used in molecular biology, primarily focusing on the analysis of nucleic acids and proteins, to facilitate the detection, characterization, or quantification of biomarkers. These methods include polymerase chain reaction (PCR), sequencing technologies, microarrays, and other sophisticated biochemical methods that are essential across various sectors such as healthcare, agriculture, environmental studies, and pharmaceuticals. The necessity of molecular methods is driven by the growing demand for personalized medicine, targeted therapies, and advanced diagnostic tools aiming to enhance treatment efficacy and patient outcomes. Applications range from research and genomic studies to clinical diagnostics and pharmaceutical development. End-users include hospitals, research institutions, biotechnology firms, and agricultural industries, among others. Key growth factors influencing the market include technological advancements in sequencing and bioinformatics, the rise of precision medicine, and increased funding for genetic research. Additionally, the COVID-19 pandemic has underscored the importance of molecular diagnostics, accelerating market adoption. Potential opportunities lie in the expansion of CRISPR technology, development of next-generation sequencing (NGS) applications, and biomarker discovery. However, challenges such as high costs, regulatory hurdles, and the need for skilled personnel impede faster market growth. Innovation and research are best directed at automating molecular methods to reduce costs and improve accessibility, enhancing data analysis capabilities through AI, and exploring novel applications in synthetic biology and gene editing. The market's nature is dynamic, with significant opportunities for those who can navigate technological complexities and regulatory landscapes. Companies are advised to invest in partnerships and research collaborations to capitalize on emerging technologies and develop comprehensive solutions that serve both niche and broad applications, thereby aligning with future market demands.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Molecular Methods Market

The Molecular Methods Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing demand for food safety
  • Rising prevalence of infectious diseases
  • Increasing applications in environmental engineering
• Market Restraints
  • Stringent regulatory norms for approval
• Market Opportunities
  • Ongoing R&D and advancements in molecular techniques
  • Rising developments in genomics filed
• Market Challenges
  • Intrinsic limitations of molecular methods

Porter's Five Forces: A Strategic Tool for Navigating the Molecular Methods Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Molecular Methods Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Molecular Methods Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Molecular Methods Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Molecular Methods Market

A detailed market share analysis in the Molecular Methods Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Molecular Methods Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Molecular Methods Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Molecular Methods Market

A strategic analysis of the Molecular Methods Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Molecular Methods Market, highlighting leading vendors and their innovative profiles. These include 3m Company, Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMerieux SA, Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd, HiMedia Laboratories LLC, Invitae Corporation, Neogen Corporation, QIAGEN GmbH, Sekisui Chemical Co., Ltd., SGS SA, Siemens AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Molecular Methods Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Biosensors, Immunoassay, Microarray, and Polymerase Chain Reaction.
• Based on Product, market is studied across Instrument, Reagents & Consumables, and Services.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing demand for food safety
    • 5.1.1.2. Rising prevalence of infectious diseases
    • 5.1.1.3. Increasing applications in environmental engineering
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulatory norms for approval
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing R&D and advancements in molecular techniques
    • 5.1.3.2. Rising developments in genomics filed
  • 5.1.4. Challenges
    • 5.1.4.1. Intrinsic limitations of molecular methods
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Molecular Methods Market, by Technology

• 6.1. Introduction
• 6.2. Biosensors
• 6.3. Immunoassay
• 6.4. Microarray
• 6.5. Polymerase Chain Reaction

7. Molecular Methods Market, by Product

• 7.1. Introduction
• 7.2. Instrument
• 7.3. Reagents & Consumables
• 7.4. Services

8. Americas Molecular Methods Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Molecular Methods Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Molecular Methods Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3m Company
• 2. Abbott Laboratories
• 3. Bio-Rad Laboratories, Inc.
• 4. bioMerieux SA
• 5. Danaher Corporation
• 6. Eurofins Scientific
• 7. F. Hoffmann-La Roche Ltd
• 8. HiMedia Laboratories LLC
• 9. Invitae Corporation
• 10. Neogen Corporation
• 11. QIAGEN GmbH
• 12. Sekisui Chemical Co., Ltd.
• 13. SGS SA
• 14. Siemens AG
• 15. Thermo Fisher Scientific Inc.